Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigida Barberio

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Cancers|August 12, 2023
Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature ReviewAlessandro Massano, Luisa Bertin, Fabiana Zingone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 8, 2022
Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumabLorenzo Bertani, Brigida Barberio, Marco Fornili, et al.
Inflammatory Bowel Diseases|April 2, 2020
Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte RatioLorenzo Bertani, Federico Rossari, Brigida Barberio, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Diet and Gut Microbiota in Inflammatory Bowel Disease: A Clinical and Nutritional PerspectiveLuisa Bertin, Sonia Facchin, Brigida Barberio, et al.
The Oncologist|August 21, 2023
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World SettingLaura Bonanno, Martina Lorenzi, Davide Massa, et al.
United European Gastroenterology Journal|December 1, 2020
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort studyStefano Festa, Maria L Scribano, Daniela Pugliese, et al.
Gut Microbes|November 1, 2024
Oral administration of <i>Lactobacillus casei</i> DG® after ileostomy closure in restorative proctocolectomy: a randomized placebo-controlled trial (microbiota and immune microenvironment in pouchitis -MEP1)Imerio Angriman, Melania Scarpa, Edoardo Savarino, et al.
The Oncologist|November 17, 2025
Machine learning identifies a distinct microbiota signature in immune checkpoint inhibitor colitis compared with inflammatory bowel diseaseBrigida Barberio, Ilaria Patuzzi, Luisa Bertin, et al.
Journal of Clinical Medicine|March 28, 2024
Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's DiseaseLuisa Bertin, Brigida Barberio, Alessandro Gubbiotti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 12, 2021
Diagnostic delay and misdiagnosis in eosinophilic oesophagitisMarco Vincenzo Lenti, Edoardo Savarino, Aurelio Mauro, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Cancers|August 12, 2023
Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature ReviewAlessandro Massano, Luisa Bertin, Fabiana Zingone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 8, 2022
Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumabLorenzo Bertani, Brigida Barberio, Marco Fornili, et al.
Inflammatory Bowel Diseases|April 2, 2020
Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte RatioLorenzo Bertani, Federico Rossari, Brigida Barberio, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Diet and Gut Microbiota in Inflammatory Bowel Disease: A Clinical and Nutritional PerspectiveLuisa Bertin, Sonia Facchin, Brigida Barberio, et al.
The Oncologist|August 21, 2023
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World SettingLaura Bonanno, Martina Lorenzi, Davide Massa, et al.
United European Gastroenterology Journal|December 1, 2020
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort studyStefano Festa, Maria L Scribano, Daniela Pugliese, et al.
Gut Microbes|November 1, 2024
Oral administration of <i>Lactobacillus casei</i> DG® after ileostomy closure in restorative proctocolectomy: a randomized placebo-controlled trial (microbiota and immune microenvironment in pouchitis -MEP1)Imerio Angriman, Melania Scarpa, Edoardo Savarino, et al.
The Oncologist|November 17, 2025
Machine learning identifies a distinct microbiota signature in immune checkpoint inhibitor colitis compared with inflammatory bowel diseaseBrigida Barberio, Ilaria Patuzzi, Luisa Bertin, et al.
Journal of Clinical Medicine|March 28, 2024
Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's DiseaseLuisa Bertin, Brigida Barberio, Alessandro Gubbiotti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 12, 2021
Diagnostic delay and misdiagnosis in eosinophilic oesophagitisMarco Vincenzo Lenti, Edoardo Savarino, Aurelio Mauro, et al.
Pageof 14